L. Kwak

Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.

J. Winter, E. Jaffe, K. Takeshita, 2005, Clinical lymphoma.

Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation

S. Neelapu, Zhenyuan Dong, S. Cha, 2023, Biomedicines.

Long-term ef fi cacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study

J. Sancho, C. Buske, M. Ogura, 2021 .

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

N. Vaidehi, M. Kortylewski, P. Swiderski, 2023, bioRxiv.

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

N. Vaidehi, M. Kortylewski, P. Swiderski, 2024, Molecular therapy. Nucleic acids.